Navigation Links
Pharmasset to Present at Goldman Sachs and Needham Healthcare Conferences
Date:6/2/2009

nt of oral therapeutics for the treatment of hepatitis C virus (HCV) and, secondarily, on the development of Racivir(R) for the treatment of human immunodeficiency virus (HIV). Our research and development efforts focus on nucleos(t)ide analogs, a class of compounds which act to inhibit the enzymes required for viral replication. We currently have three clinical-stage product candidates: R7128, a nucleoside analog for chronic HCV infections, has initiated a Phase 2b clinical trial in combination with Pegasys plus Copegus through a strategic collaboration with Roche; PSI-7851, an unpartnered, next generation HCV nucleotide analog, which recently began Phase 1 clinical studies and Racivir, for the treatment of HIV that has completed a Phase 2 clinical trial.

Pegasys(R) and Copegus(R) are registered trademarks of Roche.

Forward-Looking Statements

Pharmasset "Safe Harbor" Statement under the Private Securities Litigation Reform Act of 1995: Statements in this press release regarding our business that are not historical facts are "forward-looking statements" that involve risks and uncertainties, including without limitation, the risk that adverse events could cause the cessation or delay of any of the ongoing or planned clinical trials and/or our development of our product candidates, the risk that the results of previously conducted studies involving our product candidates will not be repeated or observed in ongoing or future studies involving our product candidates, the risk that our collaboration with Roche will not continue or will not be successful and the risk that any one or more of our product candidates will not be successfully developed and commercialized. For a discussion of these risks and uncertainties, any of which could cause our actual results to differ from those contained in the forward-looking statements, see the section of our Annual Report on Form 10-K for the fiscal year ended September 30
'/>"/>

SOURCE Pharmasset, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Roche and Pharmasset Initiate Phase IIb Clinical Trial of R7128, Most Advanced Nucleoside Polymerase Inhibitor in Development for Chronic Hepatitis C
2. Pharmasset Voluntarily Halts Clinical Studies with Clevudine in Hepatitis B Infected Patients
3. Pharmasset Initiates First Time in Human Study of PSI-7851 for the Treatment of Hepatitis C (HCV)
4. Pharmasset Reports Fiscal Year End 2008 Financial Results
5. Roche, InterMune and Pharmasset Announce Initiation of INFORM-1, the First Dual-Combination Clinical Trial with Oral Antivirals in Hepatitis C
6. Richard E.T. Smith, Ph.D. Joins Pharmasset as Vice President of Investor Relations and Corporate Communications
7. Pharmasset to Present at the UBS Global Life Sciences Conference on Wednesday, September 24th
8. Pharmasset Reports Financial Results for Quarter Ended June 30, 2008
9. Pharmasset Reports Preliminary Results of a 4-week Combination Study of R7128 for the Treatment of Chronic Hepatitis C
10. Pharmasset Announces Initiation of Combination Study of Clevudine and Viread(R) for HBV by French National Agency for Research on AIDS and Viral Hepatitis (ANRS)
11. Pharmasset Receives Notice of Allowance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... 2014 Does your doctor know what you,re smoking?  ... recommended marijuana to the over 112,000 currently registered patients under ... of the other roughly 20,300+ active physicians listed with the ... it – even though a poll in February 2014 showed ... have tried it. "With marijuana legalization underway, ...
(Date:8/29/2014)... Aug. 29, 2014 Diseases largely eradicated in ... ago are returning. Measles was declared eliminated in 2000, ... as of August 15—the highest incidence in 20 years. ... department declared whooping cough a problem of "epidemic ... sick and dying from these preventable diseases—in part because ...
(Date:8/29/2014)... 29, 2014  Abaxis, Inc. (NasdaqGS: ABAX ... and consumables to the medical, research and veterinary markets, ... Chief Executive Officer, will present at the CL King ... Tuesday, September 9, 2014 at 12:30 p.m. ET. The ... Hotel in New York City . ...
Breaking Medicine Technology:Medical Rules Marijuana Sales in Colorado But Most Doctors Still in the Dark 2Medical Rules Marijuana Sales in Colorado But Most Doctors Still in the Dark 3Medical Rules Marijuana Sales in Colorado But Most Doctors Still in the Dark 4Vaccines at the Crossroads: Outbreaks On the Rise Across America 2Vaccines at the Crossroads: Outbreaks On the Rise Across America 3Abaxis, Inc. to Present at CL King's 12th Annual Best Ideas Conference 2014 2
... Medicare Part D beneficiaries who enter the "donut ... previously subsidized prescription costs, are twice as likely to ... more affordable or generic medications, a new study published ... (Logo: http://photos.prnewswire.com/prnh/20090226/NE75914LOGO) The study conducted by researchers ...
... The National Association of Drug Diversion Investigators ... Responsibly to Ensure Safety) Alliance (SM) have joined Attorney ... issue in Florida – prescription drug abuse. Attorney General ... a statewide Drug Take Back Day. NADDI and the ...
Cached Medicine Technology:CVS Caremark, Harvard and Brigham and Women's Researchers Say Medicare 'Donut Hole' Can Lead to a Decrease in Medication Adherence 2CVS Caremark, Harvard and Brigham and Women's Researchers Say Medicare 'Donut Hole' Can Lead to a Decrease in Medication Adherence 3NADDI and the C.A.R.E.S. Alliance Join Attorney General Bondi in Fight Against Prescription Drug Abuse 2NADDI and the C.A.R.E.S. Alliance Join Attorney General Bondi in Fight Against Prescription Drug Abuse 3
(Date:8/30/2014)... 31 August 2014: A new batteryless cardiac pacemaker ... heart motion was presented at ESC Congress 2014 ... device does not require battery replacement. , Mr ... Group at ARTORG, University of Bern, Switzerland, said: ... implants. Once they reach a critically low energy ...
(Date:8/30/2014)... (PRWEB) August 31, 2014 According to the ... step by step holistic system for skin health. It seems ... already been tried by more than 138,000 patients from all ... Mike Walden, who says that this method will not only ... clear skin. , What makes this program unique among ...
(Date:8/30/2014)... (PRWEB) August 31, 2014 In a world ... dog’ approach, Karma Web Group, LLC launches a game app ... Android the newly launched Ultimate Karma app is a colorful ... new levels of play, the game pulls double-duty by teaching ... same time. , Designed to reward gamers for consistently taking ...
(Date:8/30/2014)... NY (PRWEB) August 31, 2014 This ... and fastest growing union in New York State and ... middle-class healthcare jobs and the best quality of care ... , In recent years, thousands of healthcare workers in ... and their families by becoming members of the healthcare ...
(Date:8/30/2014)... 31, 2014 Atlanta based automotive group ... help raise money and awareness for ALS by participating ... Managers, staff, and even Vice President Jimmy Ellis all ... and can be viewed on their Youtube page; ... challenge, general managers and staff also took the opportunity ...
Breaking Medicine News(10 mins):Health News:Batteryless cardiac pacemaker is based on automatic wristwatch 2Health News:Acne No More Review Reveals Unusual Tip to Eliminate Acne Permanently 2Health News:Newly Launched Ultimate Karma App Elicits Happiness in Players and Encourages Moral Values 2Health News:This Labor Day, 1199SEIU Continues Commitment to Growing Local Economies with Good, Middle-Class Healthcare Jobs 2Health News:This Labor Day, 1199SEIU Continues Commitment to Growing Local Economies with Good, Middle-Class Healthcare Jobs 3Health News:This Labor Day, 1199SEIU Continues Commitment to Growing Local Economies with Good, Middle-Class Healthcare Jobs 4Health News:Jim Ellis Automotive Group Take the ALS Ice Bucket Challenge 2
... Medical Center,s Institute for Regenerative Medicine and colleagues have discovered ... how the human body regulates blood sugar levels. Reporting in ... says the protein may represent a new target for treating ... current thinking about what causes type 1 diabetes," said Bryon ...
... Journal of Clinical Oncology shows that most patients ... surgery recover an average quality of life. However, quality of ... level that remains much lower than the average population in ... that hospitals must be better at identifying this patient group. ...
... clinical research findings in peer-reviewed biomedical journals, Yale School of ... sample of trials primarily or partially funded by the National ... completing the clinical trial. These findings appear in ... which focuses on the topic of unpublished evidence. ...
... Reporter , TUESDAY, Jan. 3 (HealthDay News) -- Obese people ... risk of heart attack, stroke and death, Swedish researchers report. ... metabolic changes that occur after the surgery, such as altered ... "Bariatric surgery is associated with about 30 percent reduction ...
... News) -- Sexual satisfaction increases with age among sexually active ... don,t have sex are satisfied with their sex lives. ... planned community in the San Diego area and whose ... average age was 67 years and 63 percent of them ...
... all wounds Wound healing requires complex interactions between ... As healing progresses, the growth of new blood vessels is ... are cells that come from the bone marrow and are ... that direct their emigration from the bone marrow are unknown. ...
Cached Medicine News:Health News:Researchers discover protein that may represent new target for treating type 1 diabetes 2Health News:Impaired quality of life: A warning signal after oesophageal cancer surgery 2Health News:Many NIH-funded clinical trials go unpublished over 2 years after completion 2Health News:Weight Loss Surgery Linked to Fewer Heart Attacks, Deaths 2Health News:Weight Loss Surgery Linked to Fewer Heart Attacks, Deaths 3Health News:Women's Sexual Satisfaction Often Rises With Age: Study 2Health News:Preview of articles to be published Jan. 3, 2012 2Health News:Preview of articles to be published Jan. 3, 2012 3Health News:Preview of articles to be published Jan. 3, 2012 4Health News:Preview of articles to be published Jan. 3, 2012 5Health News:Preview of articles to be published Jan. 3, 2012 6Health News:Preview of articles to be published Jan. 3, 2012 7Health News:Preview of articles to be published Jan. 3, 2012 8
Instrument necessary for insertion of Ritleng Bicanaliculus systems and of Self-Threading Monoka systems....
... For canalicular laceration or ... silicone and Stainless Steel Probe. ... Tubing securely swaged into malleable ... anchored by punctum plug: no ...
Recommended to insert plug portion of all monocanalicular intubation systems into punctum....
Skin Tone External Eyelid Weights...
Medicine Products: